Jingsong He
- Molecular Biology top 10%
- Oncology top 5%
- Hematology top 2%
- Immunology top 5%
- Cancer Research top 5%
- Topics
- Multiple Myeloma Research and Treatments (42 papers)Acute Myeloid Leukemia Research (19 papers)Protein Degradation and Inhibitors (18 papers)
- Cited by
- HematologyOncologyCancer Research
- Journals
- BloodGastroenterologyPLoS ONE
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jingsong He
118 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.0k
- Oncology 865
- Hematology 572
- Immunology 452
- Cancer Research 349
Countries citing papers authored by Jingsong He
This map shows the geographic impact of Jingsong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingsong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingsong He more than expected).
Fields of papers citing papers by Jingsong He
This network shows the impact of papers produced by Jingsong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingsong He. The network helps show where Jingsong He may publish in the future.
Co-authorship network of co-authors of Jingsong He
This figure shows the co-authorship network connecting the top 25 collaborators of Jingsong He. A scholar is included among the top collaborators of Jingsong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingsong He. Jingsong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 2 | |
| 10 | 7 | |
| 11 | 0 | |
| 12 | 3 | |
| 13 | 4 | |
| 14 | 35 | |
| 15 | 38 | |
| 16 | 30 | |
| 17 | 30 | |
| 18 | 139 | |
| 19 | 31 | |
| 20 | 11 |
About Jingsong He
Jingsong He is a scholar working on Hematology, Oncology and Genetics, having authored 136 papers that have together received 2.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Acute Myeloid Leukemia Research (19 papers) and Protein Degradation and Inhibitors (18 papers). The work is most often cited by research in Hematology (572 citations), Oncology (865 citations) and Cancer Research (349 citations). Jingsong He has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhen Cai, Enfan Zhang, Wen Cao, Haimeng Yan, Jianwei Qu, Ruyi Xu, Huiyao Gu, Lawrence Paszat, Linda Rabeneck and Qingxiao Chen. Their work appears in journals such as Blood, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.